Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 15/100

Failure Rate

0.0%

0 terminated/withdrawn out of 6 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

33%

2 trials in Phase 3/4

Results Transparency

50%

1 of 2 completed trials have results

Key Signals

3 recruiting1 with results

Enrollment Performance

Analytics

N/A

3(50.0%)

Phase 2

1(16.7%)

Phase 4

1(16.7%)

Phase 3

1(16.7%)

6Total

N/A(3)

Phase 2(1)

Phase 4(1)

Phase 3(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (6)

Showing 6 of 6 trials

NCT06013865Phase 4Recruiting

Empagliflozin Treatment in Kidney Transplant Recipients

Role: collaborator

NCT06495710Not ApplicableRecruiting

Arterial Stiffness and Blood Pressure

Role: collaborator

NCT07217808Not ApplicableNot Yet Recruiting

Precision-Medicine Diagnostic Support in Hospitalized Veterans With Acute Kidney Injury

Role: collaborator

NCT03856879Not ApplicableCompleted

High-quality COPD Care for People With Immune Dysfunction Through Proactive E-consults

Role: collaborator

NCT06091202Phase 3Recruiting

Tele-Collaborative Outreach to Rural Patients With Chronic Pain

Role: collaborator

NCT05254418Phase 2Completed

Effects of GLP1-RA on Ectopic Fat Deposition in Chronic Kidney Disease

Role: collaborator

All 6 trials loaded